Vertex Pharmaceuticals (VRTX) Asset Writedowns and Impairment (2009 - 2025)
Vertex Pharmaceuticals' (VRTX) quarterly Asset Writedowns and Impairment came in at $379.0 million in Q1 2025, up 4481.5% quarter-over-quarter from -$8.6 million in Q4 2019.
Vertex Pharmaceuticals (VRTX) Asset Writedowns and Impairment (2009 - 2025) Analysis & Trends
Vertex Pharmaceuticals' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $379.0 million for Q1 2025.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $379.0 million in Q1 2025; TTM through Dec 2025 was $379.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $379.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment advanced to $379.0 million in Q1 2025 per VRTX's latest filing, from -$8.6 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $379.0 million in Q1 2025 and bottomed at $379.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 379.00 Mn |
| Mar 31, 2025 | 379.00 Mn |
| Dec 31, 2019 | -8.65 Mn |
| Dec 31, 2019 | -8.65 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Jun 30, 2019 | 5.77 Mn |
| Jun 30, 2019 | 5.77 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 29.00 Mn |
| Dec 31, 2018 | 29.00 Mn |
| Sep 30, 2017 | 255.30 Mn |
| Sep 30, 2017 | 255.30 Mn |
| Dec 31, 2015 | 2.49 Mn |
| Dec 31, 2015 | 2.49 Mn |
| Dec 31, 2014 | 711,000.00 |
| Dec 31, 2014 | 711,000.00 |
| Dec 31, 2013 | 250.60 Mn |
| Dec 31, 2013 | 250.60 Mn |